Mednet Logo

What's your choice of next line therapy for a metastatic papillary RCC who has progressed on cabozantinib?

Community PollStarted

What's your choice of next line therapy for a patient with ECOG 2 with metastatic papillary RCC who has progressed on cabozantinib?

40 physicians have voted

Join Mednetto vote and see how they answered.

1 Answer
Mednet Member
Mednet Member
Medical Oncology · William C Waterfield MD
Answered on

Combination immunotherapy works well.

Join for free or sign in to see the full answer